PPM1K Knockout HAP1 Cell Line

The choice depends on whether you are studying PPM1K (PP2Cm)'s role as the mitochondrial phosphatase regulating branched-chain α-ketoacid dehydrogenase (BCKDH) or modeling its associations with maple syrup urine disease (MSUD) and cardiac metabolism. The Knockout line is the standard tool for asking whether PPM1K is required for dephosphorylating and activating the BCKDH complex — PPM1K dephosphorylates the BCKDH E1α subunit (BCKDHA) at S293, opposing BCKDK kinase and activating BCAA catabolism. Overexpression is useful for studying PPM1K's role in cardiac metabolism and heart failure contexts. For BCAA metabolism research, the EDITGENE PPM1K Knockout in HAP1 enables study of mitochondrial BCAA catabolism regulation. PPM1K variants have been associated with MSUD-spectrum disorders and elevated branched-chain amino acid/branched-chain keto acid (BCAA/BCKA) levels — relevant to metabolic disease and heart failure where BCKA accumulation has been implicated. Rescue with wild-type or catalytically-dead PPM1K is the standard specificity control. The knockout is valuable for studying BCKDK inhibitors (BT2 and related) as cardiac metabolism therapeutic candidates.

Primary applications: • BCKDH activity: phospho-BCKDHA (S293) Western blot and BCKDH enzymatic activity assays to assess PPM1K-dependent BCKDH activation. • BCAA catabolism: branched-chain amino acid (leucine, isoleucine, valine) and branched-chain keto acid (BCKA) cellular levels by LC-MS to characterize PPM1K's metabolic contributions. • Heart failure modeling: BCKA toxicity studies in cardiac-relevant heterologous contexts given PPM1K's emerging role in cardiac BCAA metabolism. • BCKDK inhibitor mechanism: BT2 and related BCKDK inhibitors specificity testing in PPM1K-null background — these compounds activate BCKDH and lower BCAA levels. EDITGENE recommends this model for researchers investigating mitochondrial BCAA metabolism, MSUD-spectrum disorders, and BCAA-related cardiac metabolism.

Yes. PPM1K rescue experiments require attention to mitochondrial targeting: • Construct design: use a codon-modified PPM1K sequence with a small C-terminal tag (FLAG, HA). PPM1K has N-terminal mitochondrial targeting sequence cleaved upon import — N-terminal tags must not disrupt processing. • Catalytically-dead rescue: active site mutations affecting Mg²⁺/Mn²⁺ coordination (typically R/D mutations in conserved metal-binding residues) abolish phosphatase activity and serve as the standard specificity control. • Mitochondrial localization validation: confirm mitochondrial matrix localization by appropriate compartment markers before functional assays. • Functional readout: rescue should restore BCKDH dephosphorylation (phospho-BCKDHA S293) and BCAA catabolism. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.